Product NDC: | 65841-654 |
Proprietary Name: | Bromocriptine mesylate |
Non Proprietary Name: | Bromocriptine mesylate |
Active Ingredient(s): | 5 mg/1 & nbsp; Bromocriptine mesylate |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65841-654 |
Labeler Name: | Cadila Healthcare Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078899 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090123 |
Package NDC: | 65841-654-01 |
Package Description: | 100 CAPSULE in 1 BOTTLE (65841-654-01) |
NDC Code | 65841-654-01 |
Proprietary Name | Bromocriptine mesylate |
Package Description | 100 CAPSULE in 1 BOTTLE (65841-654-01) |
Product NDC | 65841-654 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Bromocriptine mesylate |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20090123 |
Marketing Category Name | ANDA |
Labeler Name | Cadila Healthcare Limited |
Substance Name | BROMOCRIPTINE MESYLATE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] |